Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TMDX · against 1,336 other Healthcare companies
Ranked #396 of 1,337 · scores higher than 70% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 70–79, including TMDX · Click a bar to see the companies
Mainly thanks to its earnings yield and free cash flow yield, which are stronger than most Healthcare peers.
| Metric | TMDX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 5.7% | 1.5% | 83% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 4.2% | 4.2% | 50% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 3.4% | -1.0% | 69% | 20% | |
| Book yieldHigher is better · 1,306 reported | 22.2% | 37.9% | 31% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 396 | 27.8B USD | 70 | 55 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 396 | 317.9B CHF (≈$365.6B) | 70 | 60 |
| 396 | 3.2B EUR (≈$3.6B) | 70 | 61 |
| 396 | 4.6B USD | 70 | 61 |
| 396 | 2.3B USD | 70 | 67 |
| 396 | 25.8B USD | 70 | 75 |
| 409 | 5.1B CNY (≈$719M) | 69 | 74 |
| 409 | 225.8B JPY (≈$1.5B) | 69 | 69 |
| 409 | 2.4B EUR (≈$2.6B) | 69 | 69 |